We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Dendreon Faces Informal SEC Probe Over Provenge
Dendreon Faces Informal SEC Probe Over Provenge
July 25, 2007
Biotechnology company Dendreon said it received a letter July 9 from the New York Regional Office of the SEC notifying the company of an informal inquiry relating to its investigational prostate cancer treatment Provenge.